hide-icon
Pattern illustration of a DNA helix with a blue background for the OGT corporate brand. (1)
Featured

Deploying a customised SureSeq NGS panel for combined myeloid and lymphoid neoplasm analysis

Resource type: White paper

Technology: NGS

Application: Haematology

Kingston Health Sciences Centre partnered with OGT to create a custom SureSeq™ NGS panel for integrated myeloid and lymphoid neoplasm analysis. The solution delivered comprehensive, efficient genomic insights generated in a single assay, with OGT’s probe design optimisation significantly boosting target coverage.

View resource
featured-image
Filter by:
61 results

Deploying a customised SureSeq NGS panel for combined myeloid and lymphoid neoplasm analysis

Resource type: White paper

Technology: NGS

Application: Haematology

View resource
resource-image

How one integrated laboratory test can detect both molecular and cytogenetic driving alterations across blood cancers

Resource type: Customer presentation

Technology: NGS

Application: Haematology

View resource
resource-image

Precise and accurate detection of mutations and copy number alterations in CLL using enrichment-based targeted NGS

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource
resource-image

Evaluation of OGT’s SureSeq Myeloid Fusion Complete NGS Workflow Solution V2 for partner-agnostic fusion gene detection in acute leukaemias

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource
resource-image

Integrated analysis of diverse genomic variants for the profiling of myeloid and lymphoid neoplasms by targeted hybrid capture next-generation sequencing

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource
resource-image

Sequencing depth vs. sequencing batching

Resource type: Article

Technology: NGS

Application: Haematology

View resource
resource-image

The value of MRD assessment in AML

Resource type: Article

Technology: NGS

Application: Haematology

View resource
resource-image

The future of chronic lymphocytic leukaemia (CLL) genomics?

Resource type: Article

Technology: NGS

Application: Haematology

View resource
resource-image

Target capture NGS for use in molecular-based research of myeloid MRD

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource
resource-image

Capturing fusions in haematological malignancies through targeted RNAseq

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource
resource-image

Sequencing depth vs. VAF sensitivity

Resource type: Article

Technology: NGS

Application: Haematology

View resource
resource-image

NGS advances: Efficient fusion event detection in haematological malignancy clinical research

Resource type: Application note

Technology: NGS

Application: Haematology

View resource
resource-image